Temozolomide Capsules

Escitalopram Tablets

Product Name :Temozolomide Capsules

Trade Name : Gliogen, Temodar, Temodal, Temcad

Available Strength : 20 mg, 100 mg, 250 mg

Available Combination : Escitalopram + Clonazepam tablet

Packing : 5 Capsules/Bottle, 10 Capsules/Bottle

Pack Insert/Leaflet : Yes

Therapeutic use :Anti Cancer

Production Capacity : 1 million capsule/month

Description

What is Temozolomide?

Temozolomide Capsule is a medicine that is used for the treatment of Grade Lll And Lv Brain Tumor, Skin Cancer, Cancer Of Glial Tissue Of The Nervous System and other conditions
Temozolomide Capsule contains Temozolomide as an active ingredient.

Temozolomide Capsule works by stopping the growth of cancer cells in the body.

Detailed information related to Temozolomide Capsule’s uses, composition, dosage, side effects and reviews is listed below.

Temozolomide Capsule Uses

Temozolomide Capsule is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

  • Grade Lll And Lv Brain Tumor
  • Skin Cancer
  • Cancer Of Glial Tissue Of The Nervous System
  • Anxiety Disorder

Temozolomide Capsule Working, Mechanism of Action and Pharmacology

Temozolomide Capsule improves the patient’s condition by performing the following functions:

  • Stopping the growth of cancer cells in the body.

Temozolomide Capsule – Composition and Active Ingredients

Temozolomide Capsule is composed of the following active ingredients (salts)

  • Temozolomide

Please note that this medicine may be available in various strengths for each active ingredient listed above.

Temozolomide Capsule – Side-effects

The following is a list of possible side-effects that may occur from all constituting ingredients of Temozolomide Capsule. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.

  • Dizziness
  • Wound Infection
  • Face Swelling
  • Diarrhea
  • Dry Mouth
  • Pain

Temozolomide Capsule – Precautions & How to Use

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

  • Antiemetic prophylaxis recommended
  • Avoid activities that can cause bleeding or injury
  • Avoid people who are sick or have infections
  • Children
  • Consult doctor if treatment given for pneumocystis carinii pneumonia
  • Do not drink alcohol

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Afghanistan, Israel, Jordan, Pakistan, Russia, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth..

AFRICA: South Africa, Uganda, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, and so forth.

NORTH & SOUTH AMERICA: Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela, USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Brazil, Bahamas, Ecuador, and so forth .

EUROPE: France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Fiji, Australia, New Zealand, and so forth.

Leave a Reply

Your email address will not be published.